www.checkbiotech.org ; www.raupp.info ; www.czu.cz

As he pores over plant tissue and petri dishes in a biotech seed lab in
Johnston, Iowa, Luke Mehlo is half a world away from his home in South
Africa, March 2006 by Carey Gillam.

But though the corn fields of Iowa bear little resemblance to the arid
plains of Africa, the research centre where Mehlo toils has become home to a
unique joint venture that is merging African agricultural interests with
U.S. money and technology.

The goal is to turn sorghum -- a common U.S. row crop used in animal feed,
cereals and industrial products -- into a plant that can not only weather
devastating drought but also yield a rich blend of vitamins and minerals.
Researchers believe such a combination could help combat the hunger and
malnutrition ravaging parts of Africa.

"A lot of people have died on the African continent, quite unnecessarily,"
said Mehlo, a molecular biotechnologist who came to Iowa from South Africa
in October. "We seek to have a crop that will enable us to survive during
disasters and food shortages."

Tweaking genes

Mehlo is one of a team of African scientists who will be working in Iowa
over the next three years, tinkering with the genes of sorghum seeds.

An estimated 300 million people in arid regions of Africa rely on sorghum as
a food source along with other crops. But while conventional sorghum is
already known to do well in drought conditions, it lacks certain key
nutrients.

By taking genes from other crops as well as manipulating genes within the
sorghum plant itself, scientists believe they can remake sorghum into a more
easily digestible crop richer in vitamins A and E, iron, zinc and amino
acids and protein.

Pioneer Hi-Bred International, a subsidiary of Dupont (DD.N: Quote, Profile,
Research), is a key U.S. partner and the sole commercial player in the
endeavour. Pioneer has donated $4.8 million in gene technology, and is
lending manpower and facilities for visiting African scientists at its
Johnston headquarters.

"Africa is a place where biotechnology is necessary," said Dean Oestreich,
President of Pioneer Hi-Bred International Inc. "It would be a big step to
take and make a food crop more nutritious for people in Africa."

The patented technology donated by Pioneer has already shown feasibility in
corn seeds, making successful genetic changes in sorghum likely as well,
according to Paul Anderson, a Pioneer grain manager and a member of the
oversight committee for the "African Biofortified Sorghum" project.

Still, it is expected to take eight years and a second round of funding
before a specialized seed is ready for market.

Pioneer will have no rights to revenues from the biotech sorghum once it is
developed and commercialized, said Anderson. But the company, already locked
into tight competition in the commercial seeds market, hopes that success
with biotech sorghum might help open doors for other biotech crops in
countries currently sceptical of genetically altered crops.

Gates gives money

Chief funding for the project comes from the Bill & Melinda Gates Foundation
in partnership with the National Institutes of Health. The foundation last
summer awarded a $16.9 million grant for the project, making it the largest
of four grants handed out by the foundation for the improvement of food
through technology.

"Sorghum is a huge staple throughout the world, particularly in Africa where
people suffer from some of the worst conditions," said Carol Dahl, director
of the foundation's global health technologies group.

Indeed, millions of people in Africa are currently suffering starvation and
malnutrition as extended drought and baking heat strip them of food and
water.

Along with the sorghum project, the Gates group is funding projects aimed at
creating more nutritious bananas, cassava and rice as part of a total of
$450 million in grants for improved nutrition, disease prevention and
treatment, Dahl said.

Biotech sorghum and other crops are not expected to eradicate the
devastation caused by drought, but they could partly ease the pain,
researchers believe.

"We have to wait... until we have a complete story," said Mehlo. "But we are
already ahead of schedule and we have materials that are very very
promising. There is so much light at the end of the tunnel."

[today.reuters.co.uk]

------------------------------------------
Posted to Phorum via PhorumMail